The aim of this review was to identify, evaluate and summarize all relevant studies reporting on the clinical response to gluten challenge by adult or pediatric patients with suspected or diagnosed coeliac disease (CD) on a gluten-free diet. We evaluated the effect of gluten challenge on changes in symptoms, intestinal mucosa histology, and serum antibodies. A systematic electronic search was performed for studies published as of 1966 using PubMed and Scopus databases. In the reviewed studies, doses ranged from 0.2 to 30 g/day of wheat gluten or comprised a gluten-containing diet. The onset of symptoms upon gluten intake varied largely from days to months and did not parallel serum antibody or histological changes. Within 3 months of gluten challenge, 70%–100% of pediatric CD patients became positive for AGA-IgA and EMA-IgA antibodies and 50%–70% for AGA-IgG. A limited number of trials suggest that no more than half of adult patients developed positive AGA-IgA, EMA-IgA, tTG-IgA or DGP-IgA/IgG titers. Approximately 50%–100% of pediatric and adult patients experienced mucosal relapse of gluten provocation within 3 months, which was preceded by increased mucosal intra-epithelial lymphocytes within several days of challenge. A 3-month high-dose gluten challenge should be suitable to diagnose the majority of CD patients. In some cases prolonged challenge may be needed to verify diagnosis. Combination testing for antibodies and mucosal histology may fasten the diagnosis.
References
[1]
Coeliac Disease: Recognition and Assessment of Coeliac Disease, 2009. Available online: http://www.nice.org.uk/nicemedia/pdf/cg86fullguideline.pdf (accessed on 7 August 2013).
[2]
Richey, R.; Howdle, P.; Shaw, E.; Stokes, T.; Guideline Development Group. Recognition and assessment of coeliac disease in children and adults: Summary of NICE guidance. BMJ 2009, 338, b1684, doi:10.1136/bmj.b1684.
[3]
Walker-Smith, J.A.; Guandalini, S.; Schmitz, J.; Shmerling, D.H.; Visakopi, J.L. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch. Dis. Child 1990, 65, 909–911, doi:10.1136/adc.65.8.909.
[4]
Husby, S.; Koletzko, S.; Korponay-Szabo, I.R.; Mearin, M.L.; Phillips, A.; Shamir, R.; Troncone, R.; Giersiepen, K.; Branski, D.; Catassi, C.; et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J. Pediatr. Gastroenterol. Nutr. 2012, 54, 136–160, doi:10.1097/MPG.0b013e31821a23d0.
[5]
Rubio-Tapia, A.; Hill, I.D.; Kelly, C.P.; Calderwood, A.H.; Murray, J.A.; American College of Gastroenterology. ACG clinical guidelines: Diagnosis and management of celiac disease. Am. J. Gastroenterol. 2013, 108, 656–676, doi:10.1038/ajg.2013.79.
[6]
Hill, I.D.; Dirks, M.H.; Liptak, G.S.; Colletti, R.B.; Fasano, A.; Guandalini, S.; Hoffenberg, E.J.; Horvath, K.; Murray, J.A.; Pivor, M.; et al. Guideline for the diagnosis and treatment of celiac disease in children: Recommendations of the North American society for pediatric gastroenterology, hepatology and nutrition. J. Pediatr. Gastroenterol. Nutr. 2005, 40, 1–19, doi:10.1097/00005176-200501000-00001.
[7]
Murch, S.; Jenkins, H.; Auth, M.; Bremner, R.; Butt, A.; France, S.; Furman, M.; Gillett, P.; Kiparissi, F.; Lawson, M.; et al. Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children. Arch. Dis. Child 2013, 98, 806–811, doi:10.1136/archdischild-2013-303996.
[8]
Catassi, C.; Fasano, A. Is this really celiac disease? Pitfalls in diagnosis. Curr. Gastroenterol. Rep. 2008, 10, 466–472, doi:10.1007/s11894-008-0086-8.
[9]
Ravelli, A.; Bolognini, S.; Gambarotti, M.; Villanacci, V. Variability of histologic lesions in relation to biopsy site in gluten-sensitive enteropathy. Am. J. Gastroenterol. 2005, 100, 177–185, doi:10.1111/j.1572-0241.2005.40669.x.
[10]
Corazza, G.R.; Villanacci, V.; Zambelli, C.; Milione, M.; Luinetti, O.; Vindigni, C.; Chioda, C.; Albarello, L.; Bartolini, D.; Donato, F. Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin. Gastroenterol. Hepatol. 2007, 5, 838–843, doi:10.1016/j.cgh.2007.03.019.
[11]
Corazza, G.R.; Villanacci, V. Coeliac disease. J. Clin. Pathol. 2005, 58, 573–574, doi:10.1136/jcp.2004.023978.
[12]
Weile, B.; Hansen, B.F.; Hagerstrand, I.; Hansen, J.P.; Krasilnikoff, P.A. Interobserver variation in diagnosing coeliac disease. A joint study by Danish and Swedish pathologists. APMIS 2000, 108, 380–384.
[13]
Freeman, H.J. Refractory celiac disease and sprue-like intestinal disease. World J. Gastroenterol. 2008, 14, 828–830, doi:10.3748/wjg.14.828.
[14]
Guidelines for the Management of Patients with Coeliac Disease. British Society of Gastroenterology. Available online: www.bsg.org.uk (accessed on 8 April 2013).
[15]
United States Department of Agriculture, Agricultural Research Service. USDA National Nutrient Database for Standard Reference, Release 26. Available online: http://ndb.nal.usda.gov/ (accessed on 24 October 2013).
[16]
Setty, M.; Hormaza, L.; Guandalini, S. Celiac disease: Risk assessment, diagnosis, and monitoring. Mol. Diagn. Ther. 2008, 12, 289–298, doi:10.1007/BF03256294.
[17]
Akobeng, A.K.; Thomas, A.G. Systematic review: Tolerable amount of gluten for people with coeliac disease. Aliment. Pharmacol. Ther. 2008, 27, 1044–1052, doi:10.1111/j.1365-2036.2008.03669.x.
[18]
Hamilton, J.R.; McNeill, L.K. Childhood celiac disease: Response of treated patients to a small uniform daily dose of wheat gluten. J. Pediatr. 1972, 81, 885–893, doi:10.1016/S0022-3476(72)80538-9.
[19]
Scott, H.; Ek, J.; Baklien, K.; Brandtzaeg, P. Immunoglobulin-producing cells in jejunal mucosa of children with coeliac disease on a gluten-free diet and after gluten challenge. Scand. J. Gastroenterol. 1980, 15, 81–88, doi:10.3109/00365528009181436.
[20]
Hansson, T.; Dahlbom, I.; Rogberg, S.; Dannaeus, A.; Hopfl, P.; Gut, H.; Kraaz, W.; Klareskog, L. Recombinant human tissue transglutaminase for diagnosis and follow-up of childhood coeliac disease. Pediatr. Res. 2002, 51, 700–705, doi:10.1203/00006450-200206000-00007.
[21]
Dutch Food Composition Database Online Version 2013/4.0. Available online: http://www.rivm.nl/en/Topics/Topics/D/Dutch_Food_Composition_Database (accessed on 24 October 2013).
[22]
Van Overbeek, F.M.; Uil-Dieterman, I.G.; Mol, I.W.; K？hler-Brands, L.; Heymans, H.S.; Mulder, C.J. The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population. Eur. J. Gastroenterol. Hepatol. 1997, 9, 1097–1099, doi:10.1097/00042737-199711000-00013.
[23]
World Health Organisation. The WHO Child Growth Standards. Available online: http://www.who.int/childgrowth/en/ (accessed on 7 August 2013).
[24]
Leffler, D.; Schuppan, D.; Pallav, K.; Najarian, R.; Goldsmith, J.D.; Hansen, J.; Kabbani, T.; Dennis, M.; Kelly, C.P. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut 2012, 62, 996–1004.
[25]
Cornell, H.J.; Macrae, F.A.; Melny, J.; Pizzey, C.J.; Cook, F.; Mason, S.; Bhathal, P.S.; Stelmasiak, T. Enzyme therapy for management of coeliac disease. Anon. Scand. J. Gastroenterol. 2005, 40, 1304–1312, doi:10.1080/00365520510023855.
[26]
Tye-Din, J.A.; Anderson, R.P.; Ffrench, R.A.; Brown, G.J.; Hodsman, P.; Siegel, M.; Botwick, W.; Shreeniwas, R. The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Clin. Immunol. 2010, 134, 289–295, doi:10.1016/j.clim.2009.11.001.
[27]
Kelly, C.P.; Green, P.H.; Murray, J.A.; Dimarino, A.; Colatrella, A.; Leffler, D.A.; Alexander, T.; Arsenescu, R.; Leon, F.; Jiang, J.G.; et al. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: A randomised placebo-controlled study. Aliment. Pharmacol. Ther. 2013, 37, 252–262, doi:10.1111/apt.12147.
[28]
Leffler, D.A.; Kelly, C.P.; Abdallah, H.Z.; Colatrella, A.M.; Harris, L.A.; Leon, F.; Arterburn, L.A.; Paterson, B.M.; Lan, Z.H.; Murray, J.A. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am. J. Gastroenterol. 2012, 107, 1554–1562, doi:10.1038/ajg.2012.211.
[29]
Tack, G.J.; van de Water, J.M.; Bruins, M.J.; Kooy-Winkelaar, E.M.; van Bergen, J.; Bonnet, P.; Vreugdenhil, A.C.; Korponay-Szabo, I.; Edens, L.; von Blomberg, B.M.; et al. Consumption of gluten with gluten-degrading enzyme by celiac patients: A pilot-study. World J. Gastroenterol. 2013, 19, 5837–5847, doi:10.3748/wjg.v19.i35.5837.
[30]
Ascher, H.; Lanner, A.; Kristiansson, B. A new laboratory kit for anti-gliadin IgA at diagnosis and follow-up of childhood celiac disease. J. Pediatr. Gastroenterol. Nutr. 1990, 10, 443–450, doi:10.1097/00005176-199005000-00005.
[31]
Mayer, M.; Greco, L.; Troncone, R.; Grimaldi, M.; Pansa, G. Early prediction of relapse during gluten challenge in childhood celiac disease. J. Pediatr. Gastroenterol. Nutr. 1989, 8, 474–479, doi:10.1097/00005176-198905000-00009.
[32]
Rolles, C.J.; McNeish, A.S. Standardised approach to gluten challenge in diagnosing childhood coeliac disease. Br. Med. J. 1976, 1, 1309–1311, doi:10.1136/bmj.1.6021.1309.
Berg, N.O.; Lindberg, T. Incidence of coeliac disease and transient gluten intolerance in children in a Swedish urban community. Acta Paediatr. Scand. 1979, 68, 397–400, doi:10.1111/j.1651-2227.1979.tb05026.x.
[35]
Savilahti, E.; Viander, M.; Perkkio, M.; Vainio, E.; Kalimo, K.; Reunala, T. IgA antigliadin antibodies: A marker of mucosal damage in childhood coeliac disease. Lancet 1983, 1, 320–322.
[36]
Bonamico, M.; Sabbatella, L.; di Tola, M.; Vetrano, S.; Ferri, M.; Nenna, R.; Mariani, P.; Picarelli, A. Antiendomysial antibody detection in biopsy culture allows avoidance of gluten challenge in celiac children. J. Pediatr. Gastroenterol. Nutr. 2005, 40, 165–169, doi:10.1097/00005176-200502000-00015.
[37]
Troncone, R.; Auricchio, R.; Granata, V. Issues related to gluten-free diet in coeliac disease. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11, 329–333, doi:10.1097/MCO.0b013e3282f795f8.
[38]
Korponay-Szabo, I.R.; Kovacs, J.B.; Lorincz, M.; Gorácz, G.; Szabados, K.; Balogh, M. Prospective significance of antiendomysium antibody positivity in subsequently verified celiac disease. J. Pediatr. Gastroenterol. Nutr. 1997, 25, 56–63, doi:10.1097/00005176-199707000-00009.
[39]
Wauters, E.A.K.; Jansen, J.; Houwen, R.H.; Veenstra, J.; Ockhuizen, T. Serum IgG and IgA anti-gliadin antibodies as markers of mucosal damage in children with suspected celiac disease upon gluten challenge. J. Pediatr. Gastroenterol. Nutr. 1991, 13, 192–196, doi:10.1097/00005176-199108000-00013.
[40]
Valletta, E.A.; Trevisiol, D.; Mastella, G. IgA anti-gliadin antibodies in the monitoring of gluten challenge in celiac disease. J. Pediatr. Gastroenterol. Nutr. 1990, 10, 169–173, doi:10.1097/00005176-199002000-00004.
[41]
Maki, M.; Lahdeaho, M.L.; Hallstrom, O.; Viander, M.; Visakorpi, J.K. Postpubertal gluten challenge in coeliac disease. Arch. Dis. Child 1989, 64, 1604–1607, doi:10.1136/adc.64.11.1604.
[42]
Laurin, P.; Wolving, M.; F？lth-Magnusson, K. Even small amounts of gluten cause relapse in children with celiac disease. J. Pediatr. Gastroenterol. Nutr. 2002, 34, 26–30, doi:10.1097/00005176-200201000-00007.
[43]
Mavromichalis, J.; Brueton, M.J.; McNeish, A.S.; Anderson, C.M. Evaluation of the intraepithelial lymphocyte count in the jejunum in childhood enteropathies. Gut 1976, 17, 600–603, doi:10.1136/gut.17.8.600.
[44]
Hansson, T.; Dannaeus, A.; Kraaz, W.; Sj？berg, O.; Klareskog, L. Production of antibodies to gliadin by peripheral blood lymphocytes in children with celiac disease: The use of an enzyme-linked immunospot technique for screening and follow-up. Pediatr. Res. 1997, 41, 554–559, doi:10.1203/00006450-199704000-00016.
[45]
Schaad, U.B.; Gaze, H.; Hadorn, B. Intraepithelial lymphocytes before and after gluten challenge in children with celiac disease. Am. J. Dis. Child 1981, 135, 272–273.
[46]
Burgin-Wolff, A.; Gaze, H.; Hadziselimovic, F.; Huber, H.; Lentze, M.J.; Nusslé, D.; Reymond-Berthet, C. Antigliadin and antiendomysium antibody determination for coeliac disease. Arch. Dis. Child 1991, 66, 941–947, doi:10.1136/adc.66.8.941.
[47]
Bode, S.; Weile, B.; Krasilnikoff, P.A.; Gudmand-H？yer, E. The diagnostic value of the gliadin antibody test in celiac disease in children: A prospective study. J. Pediatr. Gastroenterol. Nutr. 1993, 17, 260–264, doi:10.1097/00005176-199310000-00005.
[48]
Danielsson, L.; Stenhammar, L.; Astrom, E. Is gluten challenge necessary for the diagnosis of coeliac disease in young children? Scand. J. Gastroenterol. 1990, 25, 957–960, doi:10.3109/00365529008997618.
[49]
Lancaster Smith, M.; Packer, S.; Kumar, P.J.; Harries, J.T. Cellular infiltrate of the jejunum after re introduction of dietary gluten in children with treated coeliac disease. J. Clin. Pathol. 1976, 29, 587–591, doi:10.1136/jcp.29.7.587.
[50]
Laurin, P.; F？lth-Magnusson, K.; Sundqvist, T. Increase in nitric oxide urinary products during gluten challenge in children with coeliac disease. Scand. J. Gastroenterol. 2003, 38, 55–60, doi:10.1080/00365520310000447.
[51]
Jansson, U.H.; Gudjonsdottir, A.H.; Ryd, W.; Kristiansson, B. Two different doses of gluten show a dose-dependent response of enteropathy but not of serological markers during gluten challenge in children with coeliac disease. Acta Paediatr. 2001, 90, 255–259.
[52]
Rolles, C.J.; Anderson, M.; McNeish, A.S. Confirming persistence of gluten intolerance in children diagnosed as having coeliac disease in infancy. Arch. Dis. Child 1975, 50, 259–263, doi:10.1136/adc.50.4.259.
[53]
Lancaster-Smith, M.; Kumar, P.J.; Dawson, A.M. The cellular infiltrate of the jejunum in adult coeliac disease and dermatitis herpetiformis following the reintroduction of dietary gluten. Gut 1975, 16, 683–688, doi:10.1136/gut.16.9.683.
[54]
Lahdeaho, M.L.; Maki, M.; Laurila, K.; Huhtala, H.; Kaukinen, K. Small-bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease. BMC Gastroenterol. 2011, 11, 129, doi:10.1186/1471-230X-11-129.
[55]
Montgomery, A.M.; Goka, A.K.; Kumar, P.J.; Farthing, M.J.; Clark, M.L. Low gluten diet in the treatment of adult coeliac disease: Effect on jejunal morphology and serum anti-gluten antibodies. Gut 1988, 29, 1564–1568, doi:10.1136/gut.29.11.1564.
[56]
Brottveit, M.; Raki, M.; Bergseng, E.; Fallang, L.E.; Simonsen, B.; L？vik, A.; Larsen, S.; L？berg, E.M.; Jahnsen, F.L.; Sollid, L.M.; et al. Assessing possible celiac disease by an HLA-DQ2-gliadin Tetramer Test. Am. J. Gastroenterol. 2011, 106, 1318–1324, doi:10.1038/ajg.2011.23.
[57]
Daveson, A.J.; Jones, D.M.; Gaze, S.; McSorley, H.; Clouston, A.; Pascoe, A.; Cooke, S.; Speare, R.; Macdonald, G.A.; Anderson, R.; et al. Effect of hookworm infection on wheat challenge in celiac disease—A randomised double-blinded placebo controlled trial. PLoS One 2011, 6, e17366.
[58]
Tack, G.J.; van de Water, J.M.; Kooy-Winkelaar, E.M.; van Bergen, J.; Meijer, G.A.; von Blomberg, B.M.; Schreurs, M.W.; Bruins, M.J.; Edens, L.; Mulder, C.J.; et al. 379 Can prolyl endoprotease enzyme treatment mitigate the toxic effect of gluten in coeliac patients? Gastroenterology 2010, 138, S54.
[59]
Kumar, P.J.; O’Donoghue, D.P.; Stenson, K.; Dawson, A.M. Reintroduction of gluten in adults and children with treated coeliac disease. Gut 1979, 20, 743–749, doi:10.1136/gut.20.9.743.
Kaukinen, K.; Peraaho, M.; Collin, P.; Partanen, J.; Woolley, N.; Kaartinen, T.; Nuutinen, T.; Halttunen, T.; M？ki, M.; Korponay-Szabo, I. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: A prospective and randomized clinical study. Scand. J. Gastroenterol. 2005, 40, 564–572, doi:10.1080/00365520510023422.
[62]
Campanella, J.; Biagi, F.; Bianchi, P.I.; Zanellati, G.; Marchese, A.; Corazza, G.R. Clinical response to gluten withdrawal is not an indicator of coeliac disease. Scand. J. Gastroenterol. 2008, 43, 1311–1314, doi:10.1080/00365520802200036.
[63]
Troncone, R.; Caputo, N.; Micillo, M.; Maiuri, L.; Poggi, V. Immunologic and intestinal permeability tests as predictors of relapse during gluten challenge in childhood coeliac disease. Scand. J. Gastroenterol. 1994, 29, 144–147, doi:10.3109/00365529409090453.
[64]
Jansson, U.H.; Kristiansson, B.; Magnusson, P.; Larsson, L.; Albertsson-Wikland, K.; Bjarnason, R. The decrease of IGF-I, IGF-binding protein-3 and bone alkaline phosphatase isoforms during gluten challenge correlates with small intestinal inflammation in children with coeliac disease. Eur. J. Endocrinol. 2001, 144, 417–423, doi:10.1530/eje.0.1440417.
[65]
Korponay-Szabo, I.; Kovacs, J.; Lorincz, M.; K？rmendy, M.; Sashegyi, J. New cases of celiac disease detected by anti-endomysial antibody test in families of gluten-sensitive patients and among children examined for non-specific gastrointestinal complaints. Orv. Hetil. 1993, 134, 15–20.
[66]
Baker, P.G.; Read, A.E. Oats and barley toxicity in coeliac patients. Postgrad. Med. J. 1976, 52, 264–268, doi:10.1136/pgmj.52.607.264.
[67]
Anand, B.S.; Piris, J.; Truelove, S.C. The role of various cereals in coeliac disease. Q. J. Med. 1978, 47, 101–110.
[68]
Leffler, D.A.; Dennis, M.; Edwards George, J.; Jamma, S.; Cook, E.F.; Schuppan, D.; Kelly, C.P. A validated disease-specific symptom index for adults with celiac disease. Clin. Gastroenterol. Hepatol. 2009, 7, 1328–1334.e3, doi:10.1016/j.cgh.2009.07.031.
[69]
Anderson, R.P.; van Heel, D.A.; Tye-Din, J.A.; Barnardo, M.; Salio, M.; Jewell, D.P.; Hill, A.V.S. T cells in peripheral blood after gluten challenge in coeliac disease. Gut 2005, 54, 1217–1223, doi:10.1136/gut.2004.059998.
[70]
Catassi, C.; Rossini, M.; Ratsch, I.M.; Bearzi, I.; Santinelli, A.; Castagnani, R.; Pisani, E.; Coppa, G.V.; Giorgi, P.L. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: A clinical and jejunal morphometric study. Gut 1993, 34, 1515–1519, doi:10.1136/gut.34.11.1515.
[71]
Hadziselimovic, F.; Bürgin-Wolff, A. P0429: Indication of gluten tolerance development in patients with coeliac disease. J. Pediatr. Gastroenterol. Nutr. 2004, 39, S218–S219, doi:10.1097/00005176-200406001-00553.
[72]
Murray, J.A. The widening spectrum of celiac disease. Am. J. Clin. Nutr. 1999, 69, 354–365.
[73]
Chang, F.; Mahadeva, U.; Deere, H. Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa. APMIS 2005, 113, 385–399, doi:10.1111/j.1600-0463.2005.apm_204.x.
[74]
Collin, P.; Wahab, P.J.; Murray, J.A. Intraepithelial lymphocytes and coeliac disease. Best Pract. Res. Clin. Gastroenterol. 2005, 19, 341–350, doi:10.1016/j.bpg.2005.01.005.
[75]
Ferguson, A.; Arranz, E.; O’Mahony, S. Clinical and pathological spectrum of coeliac disease—Active, silent, latent, potential. Gut 1993, 34, 150–151, doi:10.1136/gut.34.2.150.
[76]
Koskinen, O.; Collin, P.; Korponay-Szabo, I.; Salmi, T.; Iltanen, S.; Haimila, K.; Partanen, J.; M？ki, M.; Kaukinen, K. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease. J. Pediatr. Gastroenterol. Nutr. 2008, 47, 436–442, doi:10.1097/MPG.0b013e31817b6dec.
[77]
Raki, M.; Fallang, L.E.; Brottveit, M.; Bergseng, E.; Quarsten, H.; Lundin, K.E.; Sollid, L.M. Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc. Natl. Acad. Sci. USA 2007, 104, 2831–2836.
